40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin
about
Understanding engineered nanomaterial skin interactions and the modulatory effects of ultraviolet radiation skin exposureApplications of nanotechnology in dermatologyMicroneedles: A New Frontier in Nanomedicine DeliveryOverview about the localization of nanoparticles in tissue and cellular context by different imaging techniquesIn vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVRPhysicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriersQuantification of quantum dot murine skin penetration with UVR barrier impairmentCream formulation impact on topical administration of engineered colloidal nanoparticlesAllergic Responses Induced by the Immunomodulatory Effects of Nanomaterials upon Skin ExposureHuman skin penetration of gold nanoparticles through intact and damaged skin.Translocation of cell penetrating peptide engrafted nanoparticles across skin layersPreferential amplification of CD8 effector-T cells after transcutaneous application of an inactivated influenza vaccine: a randomized phase I trial.The extent of the uptake of plasmid into the skin determines the immune responses induced by a DNA vaccine applied topically onto the skin.Microneedle-based transcutaneous immunisation in mice with N-trimethyl chitosan adjuvanted diphtheria toxoid formulations.Comparison of two encapsulated curcumin particular systems contained in different formulations with regard to in vitro skin penetration.Delivery of a peptide via poly(D,L-lactic-co-glycolic) acid nanoparticles enhances its dendritic cell-stimulatory capacity.Human hair follicle: reservoir function and selective targeting.Titanium dioxide and zinc oxide nanoparticles in sunscreens: focus on their safety and effectiveness.A sunblock based on bioadhesive nanoparticles.Interaction of nanoparticles and cell-penetrating peptides with skin for transdermal drug deliveryNanotechnology in dermatology.Microfluidic-enabled liposomes elucidate size-dependent transdermal transport.PVP-coated, negatively charged silver nanoparticles: A multi-center study of their physicochemical characteristics, cell culture and in vivo experimentsEnhanced dermal delivery of acyclovir using solid lipid nanoparticles.Hair follicles contribute significantly to penetration through human skin only at times soon after application as a solvent deposited solid in man.Nanoparticles for applications in cellular imaging.Transcutaneous DNA immunization following waxing-based hair depilation elicits both humoral and cellular immune responsesBirch pollen influence the severity of atopic eczema - prospective clinical cohort pilot study and ex vivo penetration study.Prevention of airway inflammation with topical cream containing imiquimod and small interfering RNA for natriuretic peptide receptor.Characterization of physicochemical properties of ivy nanoparticles for cosmetic application.Hair follicle: a novel source of multipotent stem cells for tissue engineering and regenerative medicineNanoparticulate systems for polynucleotide delivery.Influence of critical parameters of nanosuspension formulation on the permeability of a poorly soluble drug through the skin--a case studyInvestigation of follicular and non-follicular pathways for polyarginine and oleic acid-modified nanoparticlesA physiologically based pharmacokinetic model for ionic silver and silver nanoparticles.Nanoparticles for transcutaneous vaccination.Squarticles as a lipid nanocarrier for delivering diphencyprone and minoxidil to hair follicles and human dermal papilla cells.Cutaneous short-interfering RNA therapy.Maximizing safe design of engineered nanomaterials: the NIH and NIEHS research perspective.Zinc oxide nanoparticles in modern sunscreens: an analysis of potential exposure and hazard.
P2860
Q23920953-56864169-4750-4620-95DC-0F9537815D91Q24170384-5A78B6E8-8EAC-49ED-9BB9-C4B9384B44F3Q26767037-0E61EC9A-7BCB-43EA-BCC0-AFD0A2973898Q26853219-DA90048B-5D41-46B7-AE7A-9D7F78D7DE48Q28290077-072F7035-8673-4104-BD8D-51465B76D3A9Q28384922-50A63E71-D7ED-408E-97B6-355CF02943E2Q28390527-092D15ED-0605-43D8-A057-625BCE3A8C25Q28393803-D9DBCD55-46DD-4260-A83C-DCB931B21825Q29248341-6284BF58-0523-4FA0-890C-D55B8CB7AEA9Q30999915-1FC4695A-0248-49AE-B3F7-BCF91BFE5AC5Q33562478-FF72517E-0AA1-4958-8F46-F548B0A4709BQ33593103-83E67B7F-5227-4B09-A344-F695FA4DAE5BQ34025333-6284489D-1239-4ECE-9ABE-77ADCFE7AE25Q34059945-A5B1B7B9-50F7-4D80-9186-FABB24DA5217Q34123008-C75F830D-826B-485A-8ABA-4A9D61A443A9Q34164104-4A34D649-2F29-4F0E-99F8-76E914033430Q34216578-2AF3EFEC-7C68-4161-9778-1C6D1E072555Q34383096-0F747844-8E7B-4665-A0C1-07915CBB1A0AQ34496024-DF81440A-30EC-42C6-BBBB-08CA2C2D8CF2Q34700358-760B782B-7FCF-4360-8E16-1719D7CF73ECQ35120307-E191C099-BE0D-4503-B8FB-C170438B2872Q35128000-6DE0B6DC-C4C0-45C3-AFC6-43A3F807FBD3Q35406276-3C740F2A-BDB5-4133-9176-438E01E06BF5Q35580996-6D5F091E-D0AB-4925-A364-5F0041080F76Q35624593-B1B8EC0B-B40F-4691-AA26-31B96F9DE8D2Q35635842-C4782E2F-017D-4FDD-BE9B-567629A59164Q36227323-EE3C3052-6CD5-4AA6-B20F-6537BC45EC0BQ36239909-F05C5D0C-6C39-45EF-A03B-7DE07DB4A0A9Q36535262-88570342-AA70-4DCC-93DD-34CFE3A997F0Q36604554-0BBA49BC-C6A5-4672-942D-8353C96F8998Q36948090-B2C3259C-E27A-407C-8749-C49D75711F9BQ37004107-1B2E6C7A-90D3-46FA-8ED5-93B27CBBEFB9Q37126390-F2AD5DC8-7B6C-48D6-99C1-245467A1F041Q37141351-F0597D4B-5DD2-415B-8924-98011B149639Q37167472-518F83B2-5E00-4539-8278-F6F90902D8EFQ37274692-1B2486A0-9E26-4EC3-AE86-7AF9D0BA5606Q37469369-8D001142-0301-454F-BC0D-8E5868CA9F0FQ37639312-C3BE44B9-A778-45CE-807B-491274CFDF9FQ37668445-18C22742-05AA-4F53-906C-05492A985984Q37783304-7DA77981-CD89-42F4-A34B-76C007C69C6B
P2860
40 nm, but not 750 or 1,500 nm, nanoparticles enter epidermal CD1a+ cells after transcutaneous application on human skin
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@ast
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@en
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@nl
type
label
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@ast
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@en
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@nl
prefLabel
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@ast
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@en
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@nl
P2093
P356
P1476
40 nm, but not 750 or 1,500 nm ...... eous application on human skin
@en
P2093
Annika Vogt
Behazine Combadiere
Hans Schaefer
Juergen Lademann
Karola M Stieler
Sabrina Hadam
Ulrike Blume-Peytavi
Wolfram Sterry
P2888
P304
P356
10.1038/SJ.JID.5700226
P407
P577
2006-06-01T00:00:00Z
P5875
P6179
1045666082